IL17-hæmmere i rampelyset på EULAR 2023
/ Lars Erik Kristensen
Anti-Infliximab Antibodies Led to Poorer Clinical Outcomes
/ Marthe Kirkesæther Brun
EULAR 2023 – UPDATE
/ BestPractice Nordic
Vocational Rehabilitation for People with Inflammatory Arthritis
/ Christina Merete Tvede Madsen